SCHEMBL1951014

SCHEMBL1951014

COC(=O)N([Si](C)(C)C)[Si](C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
NPSR1 Q6W5P4 1/20 0.32
KEAP1 Q14145 1/20 0.30
NFE2L2 Q16236 1/20 0.30
HCAR2 Q8TDS4 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28615077 0.72 ALDH1A1 (0.32) ALDH1A1
SCHEMBL1583473 0.67 ALDH1A1 (0.44) ALDH1A1NPSR1KEAP1NFE2L2HCAR2
SCHEMBL13445490 0.67 MEN1 (0.39) ALDH1A1KEAP1NFE2L2HCAR2TSHR
SCHEMBL3641200 0.65 TSHR (0.43) ALDH1A1NPSR1TSHR
SCHEMBL4350855 0.65 ALDH1A1 (0.30) ALDH1A1
SCHEMBL321042 0.65 LMNA (0.33) TSHR
SCHEMBL3360045 0.65 ALDH1A1 (0.41) ALDH1A1NPSR1KEAP1NFE2L2HCAR2
SCHEMBL2160280 0.65 ALDH1A1 (0.32) ALDH1A1TSHR
SCHEMBL208499 0.65
SCHEMBL3890266 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1195785-A1 NONAQUEOUS ELECTROLYTIC SOLUTION, ELECTRODE, AND CAPACITOR CONTAINING THE SAME Mitsui Chemicals, Inc. (JP) 2002-04-10 EP claimed
US-9899665-B2 Sodium secondary battery comprising carbonaceous material SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-02-20 US disclosed
US-20110135990-A1 SODIUM SECONDARY BATTERY SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-06-09 US disclosed
US-20100321863-A1 ACTIVATED CARBON AND PROCESS FOR PRODUCING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-12-23 US disclosed
US-20100248041-A1 NONAQUEOUS ELECTROLYTE SECONDARY BATTERY, ELECTRODE AND CARBONACEOUS MATERIAL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-30 US disclosed
US-7785495-B2 Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-08-31 US disclosed
EP-2214235-A1 NONAQUEOUS ELECTROLYTE SECONDARY BATTERY, ELECTRODE AND CARBON MATERIAL Sumitomo Chemical Company, Limited (JP) 2010-08-04 EP disclosed
EP-2093191-A1 ACTIVATED CARBON AND METHOD FOR PRODUCING THE SAME Sumitomo Chemical Company, Limited (JP) 2009-08-26 EP disclosed
US-20090103241-A1 Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-04-23 US disclosed
EP-1905740-A1 ELECTRIC DOUBLE LAYER CAPACITOR Sumitomo Chemical Company, Limited (JP) 2008-04-02 EP disclosed
EP-1195785-A1 NONAQUEOUS ELECTROLYTIC SOLUTION, ELECTRODE, AND CAPACITOR CONTAINING THE SAME Mitsui Chemicals, Inc. (JP) 2002-04-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090103241-A1 Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 CBR1, CYP24A1, CALU ALDH1A1 2159/4885NPSR1 1332/4885KEAP1 546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.